Involvement of p38-mitogen-activated protein kinase in adenosine receptor-mediated relaxation of coronary artery

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 6 57-6, 2005, Pages

  Teng, Bunyen ^a   Qin, Weixi ^a   Ansari, Habib R ^a   Mustafa, S Jamal ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Adenosine receptors; c Jun NH 2 terminal kinase; p42 44; Prostaglandin F2 ; Vascular smooth muscle

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLORO 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLURONAMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 6 N CYCLOPENTYLADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MRS 1706; PROSTAGLANDIN F2 ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DILATATION; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; CORONARY VESSELS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIMIDINES; RECEPTORS, PURINERGIC P1; SWINE; TRIAZOLES; VASODILATION;

EID: 19344369234     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00912.2004     Document Type: Article

References (49)

1. 2α, ionomycin, and thapsigargin in cat iris sphincter smooth muscle: inhibition by PD98059, KN-93, and isoproterenol. J Pharmacol Exp Ther 299: 178-186, 2001.
2. 2A-receptor antagonist ZM241385. J Cardiovasc Pharmacol 35: 322-325, 2000.
3. Armstead WM. PTK, ERK and p38 MAPK contribute to impaired NMDA-induced vasodilation after brain injury. Eur J Pharmacol 474: 249-254, 2003.
4. Beall A, Bagwell D, Woodrum D, Stoming TA, Kato K, Suzuki A, Rasmussen H, and Brophy CM. The small heat shock-related protein, HSP20, is phosphorylated on serine 16 during cyclic nucleotide-dependent relaxation. J Biol Chem 274: 11344-11351, 1999.
5. Begum N. Insulin signaling in the vasculature. Front Biosci 8: s796-s804, 2003.
6. 2A adenosine receptor mediates coronary vasodilation. J Pharmacol Exp Ther 284: 1066-1073, 1998.
7. Brophy CM, Lamb S, and Graham A. The small heat shock-related protein-20 is an actin-associated protein. J Vasc Surg 29: 326-333, 1999.
8. Chio CC, Chang YH, Hsu YW, Chi KH, and Lin WW. PKA-dependent activation of PKC, p38 MAPK and IKK in macrophage: implication in the induction of inducible nitric oxide synthase and interleukin-6 by dibutyryl cAMP. Cell Signal 16: 565-575, 2004.
9. Cuenda A, Cohen P, Buee-Scherrer V, and Goedert M. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J 16: 295-305, 1997.
10. Eckert RL, Efimova T, Balasubramanian S, Crish JF, Bone F, and Dashti S. p38 Mitogen-activated protein kinases on the body surface - a function for p38δ. J Invest Dermatol 120: 823-828, 2003.
11. Efimova T, Deucher A, Kuroki T, Ohba M, and Eckert RL. Novel protein kinase C isoforms regulate human keratinocyte differentiation by activating a p388 mitogen-activated protein kinase cascade that targets CCAAT/enhancer- binding protein α. J Biol Chem 111: 31753-31760, 2002.
12. 2B receptors. Pharmacol Rev 49: 381-402, 1997.
13. 2B receptor-mediated interleukin-8 production in human mast cells. Mol Pharmacol 55: 726-734, 1999.
14. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, and Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53: 527-552, 2001.
15. Gonzalez I, Tripathi G, Carter EJ, Cobb LJ, Salih DA, Lovett FA, Holding C, and Pell JM. Akt2, a novel functional link between p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in myogenesis. Mol Cell Biol 24: 3607-3622, 2004.
16. Haq SE, Clerk A, and Sugden PH. Activation of mitogen-activated protein kinases (p38-MAPKs, SAPKs/JNKs and ERKs) by adenosine in the perfused rat heart. FEBS Lett 434: 305-308, 1998.
17. Ishihata A, Tasaki K, and Katano Y. Involvement of p44/42 mitogen-activated protein kinases in regulating angiotensin II- and endothelin-1-induced contraction of rat thoracic aorta. Eur J Pharmacol 445: 247-256, 2002.
18. Ito T, Kozawa O, Tanabe K, Niwa M, Matsuno H, Sakai N, Ito H, Kato K, and Uematsu T. p38 MAP kinase is required for vasopressin-stimulated HSP27 induction in aortic smooth muscle cells. Hypertension 35: 673-678, 2000.
19. 2 in vascular smooth muscle cells. J Pharmacol Exp Ther 304: 761-772, 2003.
20. Karamsetty MR, Klinger JR, and Hill NS. Evidence for the role of p38 MAP kinase in hypoxia-induced pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol 283: L859-L866, 2002.
21. 2B receptors. Br J Pharmacol 126: 1796-1800, 1999.
22. Knoepp L, Beall A, Woodrum D, Mondy JS, Shaver E, Dickinson M, and Brophy CM. Cellular stress inhibits vascular smooth muscle relaxation. J Vasc Surg 31: 343-353, 2000.
23. Komalavilas P, Mehta S, Wingard CJ, Dransfield DT, Bhalla J, Woodrum JE, Molinaro JR, and Brophy CM. PI3-kinase/Akt modulates vascular smooth muscle tone via cAMP signaling pathways. J Appl Physiol 91: 1819-1827, 2001.
24. Komalavilas P, Shah PK, Jo H, and Lincoln TM. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells. J Biol Chem 274: 34301-34309, 1999.
25. Kumar S, McDonnell PC, Gum RJ, Hand AT, Lee JC, and Young PR. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 235: 533-538, 1997.
26. Marala RB and Mustafa SJ. Immunological characterization of adenosine A2A receptors in human and porcine cardiovascular tissues. J Pharmacol Exp Ther 286: 1051-1057, 1998.
27. Meloche S, Landry J, Huot J, Houle F, Marceau F, and Giasson E. p38 MAP kinase pathway regulates angiotensin II-induced contraction of rat vascular smooth muscle. Am J Physiol Heart Circ Physiol 279: H741-H751, 2000.
28. 2B receptors. Am J Physiol Heart Circ Physiol 282: H437-H444, 2002.
29. Nemoto S, Xiang J, Huang S, and Lin A. Induction of apoptosis by SB202190 through inhibition of p38β mitogen-activated protein kinase. J Biol Chem 273: 16415-16420, 1998.
30. 2B receptor-mediated hyperpolarization of porcine coronary artery endothelial cells. J Cardiovasc Pharmacol 40: 43-49, 2002.
31. Ono K and Han J. The p38 signal transduction pathway: activation and function. Cell Signal 12: 1-13, 2000.
32. Pugazhenthi S, Miller E, Sable C, Young P, Heidenreich KA, Boxer LM, and Reusch JE. Insulin-like growth factor-1 induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein. J Biol Chem 274: 27529-27535, 1999.
33. Rahman A, Anwar KN, Minhajuddin M, Bijli KM, Javaid K, True AL, and Malik AB. cAMP targeting of p38 MAP kinase inhibits thrombin-induced NF-κB activation and ICAM-1 expression in endothelial cells. Am. J Physiol Lung Cell Mol Physiol 287: L1017-L1024, 2004.
34. 2α-induced protein synthesis in smooth muscle cells. J Biol Chem 274: 12925-12932, 1999.
35. s proteins by ZM 241385 treatment of porcine coronary artery. J Cardiovasc Pharmacol 42: 736-744, 2003.
36. 2B receptors activate extracellular signal-regulated kinase ERK 1/2 and stress-activated protein kinase p38. In: XIVth World Congress of Pharmacology, San Francisco, CA: Am Soc Pharmacol Exp Ther, 2002, p. A262.
37. Schulte G and Fredholm BB. Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 15: 813-827, 2003.
38. 2+/calmodulin- dependent protein kinase II, and mitogen-activated protein kinases in volatile anesthetic-induced relaxation in newborn rabbit pulmonary artery. Anesthesiology 99: 131-137, 2003.
39. Su X, Smolock EM, Marcel KN, and Moreland RS. Phosphatidylinositol 3-kinase modulates vascular smooth muscle contraction by calcium and myosin light chain phosphorylation-independent and -dependent pathways. Am J Physiol Heart Circ Physiol 286: H657-H666, 2004.
40. 2B receptors in mice. J Cardiovasc Pharmacol 41: 562-570, 2003.
41. Talukder MA, Morrison RR, and Mustafa SJ. Comparison of the vascular effects of adenosine in isolated mouse heart and aorta. Am J Physiol Heart Circ Physiol 282: H49-H57, 2002.
42. Vaishnav D, Jambal P, Reusch JE, and Pugazhenthi S. SP600125, an inhibitor of c-jun N-terminal kinase, activates CREB by a p38 MAPK-mediated pathway. Biochem Biophys Res Commun 307: 855-860, 2003.
43. Watts SW, Florian JA, and Monroe KM. Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction. J Pharmacol Exp Ther 286: 1431-1438, 1998.
44. Wehrwein EA, Northcott CA, Loberg RD, and Watts SW. Rho/Rho kinase and phosphoinositide 3-kinase are parallel pathways in the development of spontaneous arterial tone in deoxycorticosterone acetate-salt hypertension. J Pharmacol Exp Ther 309: 1011-1019, 2004.
45. Wilden PA, Agazie YM, Kaufman R, and Halenda SP. ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways. Am J Physiol Heart Circ Physiol 275: H1209-H1215, 1998.
46. Woodrum D, Pipkin W, Tessier D, Komalavilas P, and Brophy CM. Phosphorylation of the heat shock-related protein, HSP20, mediates cyclic nucleotide-dependent relaxation. J Vasc Surg 37: 874-881, 2003.
47. Wyatt AW, Steinert JR, Wheeler-Jones CP, Morgan AJ, Sugden D, Pearson JD, Sobrevia L, and Mann GE. Early activation of the p42/p44 MAPK pathway mediates adenosine-induced nitric oxide production in human endothelial cells: a novel calcium-insensitive mechanism. FASEB J 16: 1584-1594, 2002.
48. Xiao YQ, Malcolm K, Worthen GS, Gardai S, Schiemann WP, Fadok VA, Bratton DL, and Henson PM. Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-β. J Biol Chem 277: 14884-14893, 2002.
49. Yamboliev IA, Hedges JC, Mutnick JL, Adam LP, Gerthoffer WT, Meloche S, Landry J, Huot J, Houle F, Marceau F, and Giasson E. Evidence for modulation of smooth muscle force by the p38 MAP kinase/HSP27 pathway. Am J Physiol Heart Circ Physiol 278: H1899-H1907, 2000.